NuVasive, Inc. announced the resignation of Massimo Calafiore, executive vice president and chief commercial officer, effective August 31, 2022, to become the chief executive officer of a privately-held, orthopedics technology company. Upon Mr. Calafiore's resignation, his responsibilities will be reallocated among current members of management while the Company aligns its commercial structure to its long-term strategy.
NuVasive, Inc.
Equities
NUVA
US6707041058
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-5.81% | 182B | |
-0.50% | 114B | |
-4.85% | 67.76B | |
+4.05% | 51.91B | |
+6.57% | 43.23B | |
+6.07% | 41.07B | |
+23.54% | 32.07B | |
+15.86% | 25B | |
-2.83% | 24.55B |